Calamos Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Calamos Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-416	Closed	-$281K	–	563
2025 Q4	$281K	Buy	+416	New	+$283K	0.01%	376
2022 Q4	–	Sell	-6,208	Closed	-$2.02M	–	330
2022 Q3	$2.02M	Hold	6,208	–	–	0.17%	94
2022 Q2	$2.18M	Hold	6,208	–	–	0.19%	96
2022 Q1	$3.4M	Buy	6,208 +3	+0%	+$1.58K	0.25%	86
2021 Q4	$4.09M	Buy	6,205 +5	+0.1%	+$3.14K	0.3%	78
2021 Q3	$3.86M	Hold	6,200	–	–	0.31%	76
2021 Q2	$3.92M	Hold	6,200	–	–	0.31%	76
2021 Q1	$3.03M	Hold	6,200	–	–	0.25%	84
2020 Q4	$3.1M	Sell	6,200 -12	-0.2%	-$5.37K	0.28%	76
2020 Q3	$2.44M	Hold	6,212	–	–	0.28%	71
2020 Q2	$2.05M	Hold	6,212	–	–	0.26%	72
2020 Q1	$1.5M	Hold	6,212	–	–	0.23%	71
2019 Q4	$1.62M	Sell	6,212 -3,788	-38%	-$998K	0.19%	85
2019 Q3	$2.72M	Hold	10,000	–	–	0.36%	75
2019 Q2	$2.75M	Buy	+10,000	New	+$2.46M	0.37%	73

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Calamos Wealth Management's IDXX Position: Q1 2026 in Review

Calamos Wealth Management sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 416 shares — an estimated $281K sold.

Calamos Wealth Management first reported a position in IDXX in Q2 2019 and held it in 15 quarters. The position peaked at $4.09M in Q4 2021. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Calamos Wealth Management reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
Calamos Wealth Management sold 416 Idexx Laboratories shares in Q1 2026, an estimated $281K.
Calamos Wealth Management first reported a position in Idexx Laboratories in Q2 2019 and held it in 15 quarters.
Calamos Wealth Management's Idexx Laboratories position peaked at $4.09M in Q4 2021.
1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Calamos Wealth Management's 13F filing for Q1 2026, filed 4 May 2026.